Skip to content

Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)

Sistas Informing Sistas on Topics About AIDS and PrEP

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06307028
Acronym
SISTA-P
Enrollment
23
Registered
2024-03-12
Start date
2024-01-08
Completion date
2024-11-13
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior, Risky, Health Knowledge, Attitudes, Practice, Health-Related Behavior

Keywords

Black women, HIV

Brief summary

In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C., Atlanta and New Orleans, who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the Black community.

Detailed description

Experienced facilitators will implement three cycles of six 3-hour sessions with up to 15 participants per cycle while expert panelists observe. After each session, participants and subject matter expert observers will complete brief surveys. Surveys following each session include closed and open-ended measures: six items rating how well the session conveyed core information (e.g., I am confident I can communicate more effectively \[Session 3\]; I have a better understanding of the effects of alcohol on making sexual choices, \[Session 4\]) and single-item scales to evaluate the facilitator's performance and the session overall. In open-ended measures, respondents will be prompted to elaborate on their survey responses to identify ways the session could be improved.

Interventions

BEHAVIORALSISTA-P Intervention

This intervention is a small group discussion designed specifically for Black women. The sessions cover topics including: self pride and self-care; HIV \& PrEP education; assertiveness skills training; coping skills; skills practice; and barriers and facilitators to HIV prevention and PrEP.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Black women are eligible if you: * Have sex with men * Are age 18+ * Live in Washington D.C., Atlanta, GA, or New Orleans, LA * Are not HIV+

Exclusion criteria

* HIV+

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the Intervention ScaleAt the time of post-test (after 6 sessions)5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower values indicate less feasibility and higher values indicate more feasibility; adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3
Acceptability of the Intervention ScaleAt the time of post-test (after 6 sessions).5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate less acceptability, and higher scores indicate more acceptability. adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3
Appropriateness of the Intervention ScaleAt the time of the post-test (after 6 sessions)5-item scale, range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate lower appropriateness, and higher scores indicate higher appropriateness. adapted from Weiner, B.J., Lewis, C.C., Stanick, C. et al. Psychometric assessment of three newly developed implementation outcome measures. Implementation Sci 12, 108 (2017). https://doi.org/10.1186/s13012-017-0635-3
Behavioral Intentions (Post-test)This occurred immediately before session 1 and again after session 6 (42 days after the first session was delivered; 42 days post baseline)Participants' intentions to use PrEP within the next 12 months. range 1 (strongly disagree) to 5 (strongly agree). Lower scores indicate lower behavioral intentions and higher scores indicate higher behavioral intentions. adapted from Scott RK, Hull SJ, Huang JC, et al. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C. Arch Sex Behav. 2022;51(5):2613-2624. doi:10.1007/s10508-021-02274-4

Secondary

MeasureTime frameDescription
Number of Participants Enrolled Out of All Eligible ParticipantsAt the end of each Session 1Initial outcome was 8-12 participants enrolled per cycle (3). The research team revised to accommodate smaller groups of 5-8 participants. Each participant was counted by the researchers if they attended Session 1 in each cycle (city).
Number of Participants Enrolled That Are Potentially PrEP Eligible Black WomenAt the time of session 1proportion of participants enrolled who are potentially PrEP eligible Black women (benchmark: 100%)
Acceptability of the Intervention Delivery (Acceptability)At the time of post-test (after 6 sessions)10-point scale assessment of facilitator performance, with 1 indicating "poor" and 10 indicating "excellent" performance. Higher scores indicated greater acceptability of the intervention delivery, and lower scores indicated lower acceptability. Benchmark: average acceptability rating of \>7.5/10
Participant RetentionAt the time of post-test (after 6 sessions).Proportion of Session 1 participants who complete session 6. Benchmark: 80%
Visual Confirmation of Self-reported PrEP UptakeAt the time of post-test (after 6 sessions)Photo confirmation of self-reported PrEP use.
Number of Participants Who Completed Post-intervention SurveysAt the time of post-test (after 6 sessions)Proportion of post-intervention surveys completed. The researchers administered surveys and counted how many participants completed the surveys. Benchmark: 80%

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORShawnika Hull, PhD

Rutgers University School of Communication and Information

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
Age, Continuous43.48 years
STANDARD_DEVIATION 12.11
Pretest Behavioral Intentions2.96 units on a scale
STANDARD_DEVIATION 1.33
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
23 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
23 Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 23
other
Total, other adverse events
0 / 23
serious
Total, serious adverse events
0 / 23

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026